Xenetic Biosciences, Inc. (XBIO) — SC 13D/A Filings
All SC 13D/A filings from Xenetic Biosciences, Inc.. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
CLS Therapeutics Amends 13D Filing for Xenetic Biosciences
— Mar 18, 2024 Risk: medium
CLS Therapeutics LLC, led by Georgy Tetz, filed an amendment (No. 2) to its Schedule 13D on March 18, 2024, regarding its holdings in Xenetic Biosciences, Inc.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX